Volver a Agenda
Am I impacted by BREXIT ?
Session Chair(s)
Vicki Edwards, RPh
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
Brian Edwards, DrMed
Vice President
International Society of Pharmacovigilance, United Kingdom
This session will address some of the uncertainty surrounding the QPPV role and Brexit. What are practical implications of Brexit for UK based QPPVs? What is the impact for MAHs if QPPV moves and the team remains UK based? What is the legal situation concerning the definition ‘reside and operate in the EU? Does this mean meeting rules for residency rather than just ‘work out of’? Will there be an impact on the deputy QPPV (or ‘back-up’)? These questions and more we’ll try and answer in what promises to be a lively discussion.
Speaker(s)
Mick Foy
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Director of Delivery
Turning Confusing Political Scenarios into Workable Plans
Tim Sarson
KPMG, United Kingdom
Partner, Life Sciences Lead for Brexit
Vicki Edwards, RPh
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Elspeth McIntosh, MBA, RN
Castle Pharmacovigilance Ltd, United Kingdom
Director
¿Tiene una cuenta?